Dr. Xingguang Luo was a Psychiatrist in China. He received his medical degree in 1993 and his Ph.D. in 2000. He came to Yale University as a postdoctoral associate in 2000. During working in the Department of Psychiatry, Yale University School of Medicine, he was promoted to Associate Research Scientist in 2003 and Assistant Professor in 2006. Dr. Luo has focused on the genetics and epigenetics of neuropsychiatric and substance use (with an emphasis on alcohol, nicotine, cocaine and opioid use) disorders. In recent years, he is especially interested in genome-wide association studies, genome-wide DNA sequencing, transcriptome-wide RNA sequencing, microarray of non-coding RNAs, chromatin remodeling, histone modification and DNA methylation studies of these disorders. Over these years, Dr. Luo has authored over 130 peer-reviewed scientific publications and earned numerous research grant funds. He is also a reviewer for NIH (USA), MRC (UK), Welcome Trust Foundation (UK) and DBT (UK-India) grants.

Genome-wide association studies; Third-generation sequencing technology; Pharmacogenetics; DNA methylation